The CRF₁ receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal

Author： Skelton Kelly Gutman David Thrivikraman K. Nemeroff Charles Owens Michael

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.192, Iss.3, 2007-06, pp. : 385-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antidepressant-like effects of CP-154,526, a selective CRF 1 receptor antagonist

By Mansbach R.S. Brooks E.N. Chen Y.L.

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 21-26

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D. Scates S.M. Lowe J.A. Martin B.R.

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Physical withdrawal in rats tolerant to 9 -tetrahydrocannabinol precipitated by a connabinoid receptor antagonist

By Tsou K. Patrick S.L. Walker J.M.

European Journal of Pharmacology, Vol. 280, Iss. 3, 1995-07 ,pp. : 13-15

Elsevier

Access to resources Recommend Favorite

CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats

By Moffett M. Goeders N.

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 171-180

Springer Publishing Company

Access to resources Recommend Favorite

The CRF 1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats

By Lejeune F. Millan M.J.

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite